✦ LIBER ✦

712 A Multi-Centre, Parallel Group, Randomised Placebo Controlled Trial of Mesalazine for Treatment of Diarrhoea-Predominant Irritable Bowel Syndrome (IBS-D)

✍ Scribed by Lam, Ching; Tan, Wei; Leighton, Matthew; Williams, Jessica; Agrawal, Anurag; Sen, Sandip; Foley, Stephen; Rutter, Matt; Ramadas, Arvind; Whorwell, Peter J.; Montgomery, Alan; Spiller, Robin C.

Book ID: 122179385
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 434 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)60444-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and mode of action of mesalazin

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial

✍ Matthew P Leighton, Ching Lam, Samir Mehta, Robin C Spiller 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 275 KB

520 Efficacy of Ibodutant, a Selective A

520 Efficacy of Ibodutant, a Selective Antagonist of Neurokinin 2 Receptors, in Irritable Bowel Syndrome With Diarrhoea (IBS-D): The Results of a Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Phase II Study (the IRIS-2)

✍ Tack, Jan F.; Dochev, Yavor S.; Bochenek, Anna; Atanasov, Ivan; Horynski, Marek; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 639 KB